SV Health Investors is a specialist healthcare fund manager, investing across stages, geographic regions, and sectors, with expertise spanning biotechnology, dementia, healthcare growth, healthcare technology and public equities.
Alongside our core funds, SV manages the Dementia Discovery Fund, focused on discovering and developing novel therapeutics for dementia, and International Biotechnology Trust plc, a publicly-traded investment trust.
|
|
|
|
|
51-200 employees
View all SV Health Investors employees
|
|
|
Venture Capital & Private Equity
|
|
|
First Floor, 71 Kingsway, Holborn, London, London WC2B 6ST, GB
|
|
|
1993
|
|
|
Biotechnology, Venture Capital, Private Equity, Dementia, Medical Devices, Healthcare Services
|
The decision makers in SV Health Investors are Charles Dunn, Georgina Ewels, James Costine, etc. Click to Find SV Health Investors decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.